Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 20 points (-0.2%) at 12,795 as of Monday, Nov. 12, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,283 issues advancing vs. 1,555 declining with 129 unchanged. The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include ResMed ( RMD), down 3.2%, St Jude Medical ( STJ), down 1.7% and Becton Dickinson ( BDX), down 0.8%. TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today: 5. Edwards Life ( EW) is one of the companies pushing the Health Services industry lower today. As of noon trading, Edwards Life is down $1.53 (-1.7%) to $86.17 on light volume Thus far, 133,599 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $86.10-$87.88 after having opened the day at $87.86 as compared to the previous trading day's close of $87.70. Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. Edwards Life has a market cap of $10.0 billion and is part of the health care sector. The company has a P/E ratio of 38.0, above the S&P 500 P/E ratio of 17.7. Shares are up 22.5% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 7 rate it a hold. TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Edwards Life Ratings Report now.